RxDoctor Payments Data

Farhad Chowdhury, DO

Otolaryngology · Old Bridge, NJNPI 1063656882

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $919, 2.4 times the $385 reported in 2019.

$2,871in general payments, 2019–2025

Across 140 payments — averaging $20.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$495
  • Sanofi$413
  • Optinose US, Inc.$299
  • GSK$297
  • Regeneron Healthcare Solutions, Inc.$213
  • AstraZeneca$194
  • plus $960 from 18 others

What the payments were for

  • Food & beverage$2,871100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,871 in reported general payments places this provider in the 75th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$349,919
Medicare patients
676
Services billed
2,357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate375$5,105
Azelastine-FluticasoneAzelastine/Fluticasone20$2,939
Azelastine Hcl109$2,728
Ipratropium Bromide66$2,275
Fluocinolone Acetonide Oil47$2,234
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth12$1,140
Famotidine140$1,062
Methylprednisolone105$636
Levocetirizine Dihydrochloride55$497
Omeprazole27$482
Montelukast Sodium17$273
Azithromycin20$154
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$141
Mupirocin17$110

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Old Bridge

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →